FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101442 [Registered on: 19/01/2026] Trial Registered Prospectively
Last Modified On: 17/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Study of liver fibrosis using blood based tests and liver stiffness measurement 
Scientific Title of Study   Diagnostic performance of FIB-4 , FIB -5 and APRI score for predicting liver fibrosis : A cross sectional study using Liver Stiffness Index as a reference 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Karthik Chandra 
Designation  Junior Resident 
Affiliation  Kasturba Medical College, Manipal 
Address  Department of General Medicine Kasturba Medical College Manipal

Udupi
KARNATAKA
576104
India 
Phone  9956270570  
Fax    
Email  karthikchandra616@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Karthik Chandra 
Designation  Junior Resident 
Affiliation  Kasturba Medical College, Manipal 
Address  Department of General Medicine Kasturba Medical College Manipal

Udupi
KARNATAKA
576104
India 
Phone  9956270570  
Fax    
Email  karthikchandra616@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Karthik Chandra 
Designation  Junior Resident 
Affiliation  Kasturba Medical College, Manipal 
Address  Department of General Medicine Kasturba Medical College Manipal

Udupi
KARNATAKA
576104
India 
Phone  9956270570  
Fax    
Email  karthikchandra616@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Karthik Chandra 
Address  Department of General Medicine Kasturba Hospital Manipal 576104  
Type of Sponsor  Other [Self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Adarsha G K  Kasturba Hospital, Manipal  Room number 12 Faculty Room OPD Block Department of General Medicine
Udupi
KARNATAKA 
9591706468

adarsha.gk@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee - 2 (Student Research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K740||Hepatic fibrosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Adult greater than 18 years undergoing calculation of Liver Stiffness Index and have reports of Complete Blood Counts and Liver function tests within 3 months of calculation of Liver Stiffness Index 
 
ExclusionCriteria 
Details  Participants will be excluded from the study if they meet any of the following conditions:
1. Acute Hepatic Injury
2. Pregnancy
3. Haematological Disorders Affecting Platelet Counts
4. Decompensated Cirrhosis
5. Severe Extrahepatic Illnesses
6. Recent Major Physiological Stressors 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary outcome measure of this study is the diagnostic performance of existing non-invasive fibrosis scores—namely FIB-4, APRI, and FIB-5—in predicting liver fibrosis as assessed by the Liver Stiffness Index (LSI) measured via transient elastography.

AUROC (Area Under the Receiver Operating Characteristic Curve) for each score in identifying mild, moderate, and severe fibrosis grades.
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each fibrosis score compared to the Liver Stiffness Index.
Distribution of fibrosis scores across different LSI strata to evaluate consistency of classification.

 
2 years 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="11" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective cross-sectional observational study conducted in adult patients undergoing liver stiffness assessment as part of routine clinical evaluation. The study aims to assess and compare the diagnostic performance of commonly used non-invasive liver fibrosis scores, namely FIB-4, APRI, and FIB-5, using the Liver Stiffness Index as the reference standard. Relevant clinical details and laboratory parameters will be obtained from existing medical records, without performing any additional investigations or interventions. The diagnostic accuracy of each score will be evaluated using receiver operating characteristic (ROC) curve analysis, along with sensitivity, specificity, and related performance measures. 
Close